Postmenopause Women
Postmenopause Women - Related Videos
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
0 Views •
Cited by 40 •
2018
This manuscript describes the Research Prioritization by Affected Communities (RPAC) protocol and findings from its use with women at risk for preterm birth. Using the protocol, women identified and prioritized their unanswered questions about pregnancy, birth and neonatal care aimed at influencing research priority setting by funders and researchers.
08:07
Electromyometrial Imaging of Uterine Contractions in Pregnant Women
0 Views •
Cited by 2 •
2023
We present a protocol for conducting electromyometrial imaging (EMMI), including the following procedures: multiple electromyography electrode sensor recordings from the body surface, magnetic resonance imaging, and uterine electrical signal reconstruction.
07:20
Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
0 Views •
Cited by 1 •
2024
Postmenopausal osteoporosis has become a global public health problem. The aim of this study is to explore the therapeutic effects and related mechanisms of the traditional Chinese medicine Xiaoyao pills on this condition.
08:42
Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
0 Views •
Cited by 3 •
2015
We aim to identify the neural correlates underlying sustained and transient thought suppression, and thought re-emergence in controls, at-risk and depressed individuals. Activation was greatest for controls compared to the at-risk and the depressed group in the dorsolateral prefrontal cortex during thought suppression and anterior cingulate cortex during thought re-emergence.
14:26
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
0 Views •
Cited by 16 •
2014
Two exercise paradigms were tested on a newly developed chemically induced menopausal mouse model to examine the impact of menopause on exercise capacity and cardiac adaption to exercise.
FAQs
Inherited variants can help explain why postmenopausal women differ in bone density, disease susceptibility, or treatment response. Their effects are not interpreted in isolation; researchers examine how genetic differences interact with aging and lifetime hormone exposure. This approach connects genomic variation with the endocrine and biological conditions characteristic of later life, supporting more specific analyses of health outcomes.
Lifetime hormone exposure provides an important context for interpreting genetic effects after ovarian follicle activity has declined. Two women may carry relevant inherited variants but differ in how those variants relate to later-life biology because their hormonal histories differ. Considering this interaction helps researchers study how genetics and reproductive life-stage factors jointly influence bone, cardiovascular, and metabolic outcomes.
Reduced estrogen alongside persistently elevated follicle-stimulating hormone and luteinizing hormone creates an endocrine setting in which genetic effects can be examined during later life. This hormonal environment links inherited variation and gene regulation to biological traits such as bone density and metabolic or cardiovascular health. It therefore provides context for interpreting associations identified in postmenopausal women.
Life-stage comparisons can reveal whether a genetic association is specific to postmenopause or reflects a broader pattern across aging. The postmenopausal endocrine context differs from earlier reproductive stages, so the same inherited variant or regulatory process may show different relationships with health outcomes. Such comparisons strengthen sex- and life-stage-specific analysis rather than treating women as a uniform group.
A focused study can consider inherited variants, gene regulation, aging, lifetime hormone exposure, and measurable outcomes such as bone density, disease susceptibility, or treatment response. Examining these factors together helps researchers distinguish genetic effects from life-stage and hormonal context. It also supports interpretation of how genomic information relates to multiple aspects of health in later life.
Researchers can use this population to examine whether inherited variation and gene regulation are associated with differences in bone density or susceptibility to disease under postmenopausal endocrine conditions. Including aging and lifetime hormone exposure adds biological context to those relationships. The resulting analysis may clarify why health risks differ among women at the same broad life stage.
Treatment response provides a way to investigate whether genetic differences are associated with differing outcomes among postmenopausal women. Researchers can interpret those differences alongside gene regulation, aging, and lifetime hormone exposure rather than considering genetics alone. This supports life-stage-specific analysis of how inherited biology may relate to the effectiveness or observed response to treatments.
Postmenopausal women offer a defined life-stage context for studying interactions among inherited variants, gene regulation, aging, and hormone exposure. Findings can connect genomic differences with bone, cardiovascular, metabolic, and disease-related outcomes. More broadly, this population supports research designs that account for both sex and life stage when investigating human health and variability.